BioMarin Pharmaceutical Inc. (BMRN)

BioMarin Pharmaceutical Market Cap

BioMarin Pharmaceutical has a market cap or net worth of $17.31 billion as of April 24, 2024. Its market cap has decreased by -7.49% in one year.

• Market Cap: 17.31B
• Enterprise Value: 17.32B
• 1-Year Change: -7.49%
• Ranking: #585
• Category: Large-Cap
• Stock Price: $91.20

Market Cap Chart

Since July 26, 1999, BioMarin Pharmaceutical's market cap has increased from $443.40M to $17.31B, an increase of 3,803.36%. That is a compound annual growth rate of 15.95%.

Market Cap History

Date	Market Cap	% Change
Apr 23, 2024	17.37B	2.87%
Apr 22, 2024	16.88B	0.97%
Apr 19, 2024	16.72B	-1.60%
Apr 18, 2024	16.99B	-0.44%
Apr 17, 2024	17.07B	-0.44%
Apr 16, 2024	17.15B	-0.70%
Apr 15, 2024	17.27B	-0.77%
Apr 12, 2024	17.40B	0.83%
Apr 11, 2024	17.26B	1.39%
Apr 10, 2024	17.02B	1.38%
Apr 9, 2024	16.79B	1.95%
Apr 8, 2024	16.47B	0.38%
Apr 5, 2024	16.41B	0.07%
Apr 4, 2024	16.39B	0.13%
Apr 3, 2024	16.37B	-0.02%
Apr 2, 2024	16.38B	-0.34%
Apr 1, 2024	16.43B	-0.27%
Mar 28, 2024	16.48B	-1.43%
Mar 27, 2024	16.72B	0.99%
Mar 26, 2024	16.55B	1.41%
Mar 25, 2024	16.32B	1.63%
Mar 22, 2024	16.06B	1.21%
Mar 21, 2024	15.87B	-0.77%
Mar 20, 2024	15.99B	-0.60%
Mar 19, 2024	16.09B	1.74%

View and export this data all the way back to 1999. Sign Up Today.

Related Stocks

Company	Market Cap
Koninklijke Philips	18.11B
The Cooper Companies	17.97B
Hologic	17.69B
Waters	17.53B
Laboratory Corporation of America Holdings	16.94B
Walgreens Boots Alliance	15.74B
Skye Bioscience	15.68B
BeiGene	14.45B